<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 1.6: Hormonal Optimization and Endocrine Biomarkers</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/GOLD theme for Biomarkers */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
        }

        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #475569;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Stats Highlight */
        .stat-highlight {
            background: #fffbeb;
            border: 1px solid #fde68a;
            padding: 15px 20px;
            border-radius: 10px;
            display: inline-block;
            margin: 10px 0;
            font-weight: 600;
            color: #92400e;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 30px 35px;
            margin-top: 45px;
            border-radius: 16px;
            color: white;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            margin: 0 0 20px 0;
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 1px;
            color: #D4A84B;
        }

        .takeaways-box ul {
            margin: 0;
            padding-left: 20px;
        }

        .takeaways-box li {
            margin-bottom: 12px;
            opacity: 0.95;
        }

        /* References Box */
        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f8fafc;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            font-size: 14px;
            color: #64748b;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .references-list {
            list-style: none;
            padding: 0;
            margin: 0;
            font-size: 13px;
            color: #64748b;
            line-height: 1.6;
        }

        .references-list li {
            margin-bottom: 10px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        .lesson-footer .brand {
            color: #1e3a8a;
            font-weight: 600;
            margin: 0;
            font-size: 15px;
        }

        .lesson-footer .copyright {
            color: #888;
            font-size: 13px;
            margin: 10px 0 0 0;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 1: A: Assess Biomarkers</p>
            <h1 class="lesson-title">Lesson 1.6: Hormonal Optimization and Endocrine Biomarkers</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 6 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#somatotropic"><span class="section-num">1</span>The Somatotropic Axis</a></li>
                <li><a href="#dhea"><span class="section-num">2</span>DHEA-S: Resilience Marker</a></li>
                <li><a href="#sexhormones"><span class="section-num">3</span>Sex Hormone Balance</a></li>
                <li><a href="#hpa-axis"><span class="section-num">4</span>HPA-Axis and Cortisol</a></li>
                <li><a href="#thyroid"><span class="section-num">5</span>Thyroid Vitality</a></li>
                <li><a href="#shbg"><span class="section-num">6</span>SHBG & Bioavailability</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the U-shaped relationship between IGF-1 and longevity for personalized targeting.</li>
                <li>Evaluate DHEA-S as a primary biomarker for physiological age and adrenal resilience.</li>
                <li>Identify optimal ranges for sex hormones to support tissue preservation and cognitive health.</li>
                <li>Interpret the Cortisol Awakening Response (CAR) to assess HPA-axis dysfunction.</li>
                <li>Move beyond TSH to assess metabolic vitality through Free T3 and Reverse T3 ratios.</li>
            </ul>
        </div>

        <p>In previous lessons, we explored the "hard" infrastructure of longevity: epigenetic clocks, metabolic markers, and cardiovascular risk profiles. However, the <span class="highlight">endocrine system</span> acts as the body's softwareâ€”the signaling network that determines whether cells are in a state of growth, repair, or senescence. As an Anti-Aging & Longevity Coach, understanding endocrine biomarkers is not about "bodybuilding" or "hormone replacement" in the traditional sense; it is about <strong>signal optimization</strong> within the <span class="highlight">A.G.E.L.E.S.S. Longevity Protocolâ„¢</span>.</p>

        <h2 id="somatotropic">1. The Somatotropic Axis: The IGF-1 Conundrum</h2>
        <p>The Growth Hormone (GH) / Insulin-like Growth Factor 1 (IGF-1) axis is perhaps the most debated area in longevity science. In simple organisms (like <em>C. elegans</em>) and certain mouse models, <em>low</em> IGF-1 signaling is strongly associated with extended lifespan. However, in humans, the relationship is a <span class="highlight">U-shaped curve</span>.</p>

        <div class="stat-highlight">
            A 2021 meta-analysis of over 30,000 participants found that both very low (&lt;70 ng/mL) and very high (&gt;200 ng/mL) IGF-1 levels were associated with increased all-cause mortality.
        </div>

        <p>The "sweet spot" for longevity appears to be the <strong>median to low-median range</strong> (typically 115â€“150 ng/mL for adults), depending on age. High IGF-1 drives cellular proliferation, which increases cancer risk; conversely, excessively low IGF-1 contributes to sarcopenia (muscle loss), frailty, and cognitive decline. In the A.G.E.L.E.S.S. framework, we monitor IGF-1 to ensure the client has enough "signal" for repair without over-stimulating growth pathways like mTOR.</p>

        <h2 id="dhea">2. DHEA-S: The 'Mother Hormone' of Resilience</h2>
        <p>Dehydroepiandrosterone sulfate (DHEA-S) is the most abundant circulating steroid hormone in humans. It serves as a precursor to both androgens and estrogens and acts as a neurosteroid. Unlike other hormones, DHEA-S peaks in the mid-20s and declines by approximately <span class="highlight">10-20% per decade</span>â€”a process known as <strong>adrenopause</strong>.</p>

        <p>DHEA-S is a powerful biomarker for <strong>biological age</strong>. Higher levels are correlated with improved bone density, immune function, and cardiovascular health. In the context of longevity coaching, we view DHEA-S as a buffer against the catabolic effects of cortisol. A low DHEA-S/Cortisol ratio is often a harbinger of "inflammaging" and metabolic breakdown.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Biomarker</th>
                        <th>Conventional "Normal"</th>
                        <th>Longevity Optimal (A.G.E.L.E.S.S.)</th>
                        <th>Longevity Rationale</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>DHEA-S (Male)</td>
                        <td>80 - 450 Âµg/dL</td>
                        <td>350 - 450 Âµg/dL</td>
                        <td>Protects against sarcopenia/CVD</td>
                    </tr>
                    <tr>
                        <td>DHEA-S (Female)</td>
                        <td>40 - 320 Âµg/dL</td>
                        <td>250 - 320 Âµg/dL</td>
                        <td>Supports libido, mood, and bone</td>
                    </tr>
                    <tr>
                        <td>IGF-1</td>
                        <td>50 - 300 ng/mL</td>
                        <td>115 - 150 ng/mL</td>
                        <td>Balances repair vs. cancer risk</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="sexhormones">3. Sex Hormone Assessment: Tissue Preservation</h2>
        <p>As we age, the decline in sex hormones (Testosterone, Estrogen, Progesterone) accelerates the aging of specific tissues. For longevity, we are not looking for "supraphysiological" levels, but rather the preservation of the <span class="highlight">hormonal milieu</span> that prevents age-related decay.</p>

        <h3>Testosterone (Total & Free)</h3>
        <p>In both men and women, testosterone is vital for maintaining muscle mass (preventing sarcopenia) and insulin sensitivity. Low testosterone in men is associated with a <span class="highlight">40% increase in all-cause mortality</span>. However, the focus must be on <strong>Free Testosterone</strong>â€”the fraction not bound to proteinsâ€”which is the only form capable of entering cells to exert biological effects.</p>

        <h3>Estrogen & Progesterone</h3>
        <p>For women, the transition through menopause represents a massive "biological shock" to the cardiovascular and skeletal systems. Estrogen is cardioprotective and neuroprotective. Progesterone is essential for sleep quality and GABAergic signaling in the brain. Monitoring the <strong>PG/E2 ratio</strong> is critical for managing systemic inflammation during the perimenopausal transition.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Failing" Executive</p>
                    <p style="margin:0; font-size:13px; color:rgba(255,255,255,0.8)">Hormonal Imbalance vs. Resilience</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James, 52</h4>
                        <p>Symptoms: Brain fog, mid-section weight gain, loss of "drive," poor recovery from exercise.</p>
                    </div>
                </div>
                <p><strong>Initial Biomarkers:</strong> Total Testosterone: 340 ng/dL (Low-Normal), SHBG: 58 nmol/L (High), Free Testosterone: 5.2 pg/mL (Low), DHEA-S: 110 Âµg/dL (Low), TSH: 2.8 ÂµIU/mL.</p>
                <p><strong>Intervention:</strong> Focused on the A.G.E.L.E.S.S. protocolâ€”specifically <em>Stress Management</em> to lower SHBG and <em>Micronutrient Optimization</em> (Zinc, Boron, Vitamin D) to support DHEA-S production. Strength training was adjusted to high-intensity, low-volume to avoid overtaxing the HPA-axis.</p>
                <p><strong>Outcomes:</strong> After 4 months, Free Testosterone rose to 9.8 pg/mL (without TRT), DHEA-S reached 240 Âµg/dL. James reported a "total reversal" of brain fog and a 4% reduction in body fat.</p>
            </div>
        </div>

        <h2 id="hpa-axis">4. Cortisol Awakening Response (CAR) and Diurnal Rhythms</h2>
        <p>Cortisol is often labeled the "stress hormone," but for longevity, it is the <strong>rhythm</strong> that matters more than the absolute level. The <span class="highlight">Cortisol Awakening Response (CAR)</span> is the sharp rise in cortisol (typically 50-75%) that occurs in the first 30 minutes after waking.</p>

        <p>A robust CAR indicates a healthy HPA-axis and strong circadian entrainment. A "flat" CAR is associated with:</p>
        <ul>
            <li>Chronic fatigue syndrome</li>
            <li>Systemic inflammation</li>
            <li>Increased risk of autoimmune flare-ups</li>
            <li>Accelerated hippocampal atrophy (brain aging)</li>
        </ul>
        <p>Conversely, elevated evening cortisol is a primary driver of <span class="highlight">insulin resistance</span> and sleep fragmentation, both of which shorten healthspan.</p>

        <h2 id="thyroid">5. Thyroid Optimization: Beyond TSH</h2>
        <p>Most clinical assessments stop at TSH (Thyroid Stimulating Hormone). For longevity, this is insufficient. TSH is a pituitary signal, not a measure of cellular metabolic activity. To assess the "metabolic engine," we must look at:</p>

        <ul>
            <li><strong>Free T3 (FT3):</strong> The active hormone that drives mitochondrial respiration and thermogenesis.</li>
            <li><strong>Reverse T3 (rT3):</strong> The "brake" on the system. High rT3 occurs during periods of chronic stress, calorie deprivation, or illness, effectively slowing the metabolism to conserve energy.</li>
            <li><strong>FT3/rT3 Ratio:</strong> This is the ultimate biomarker for cellular metabolic efficiency. A low ratio suggests the body is in a "survival mode" rather than a "thrival mode."</li>
        </ul>

        <div class="stat-highlight">
            A 2017 study published in <em>The Journal of Clinical Endocrinology & Metabolism</em> showed that a higher FT3/rT3 ratio was independently associated with better physical performance and lower mortality in the elderly.
        </div>

        <h2 id="shbg">6. SHBG: The Bioavailability Regulator</h2>
        <p>Sex Hormone Binding Globulin (SHBG) is a protein produced by the liver that binds to testosterone and estrogen, rendering them inactive. As we age, SHBG often rises, especially in the presence of high estrogen or low insulin.</p>

        <p><strong>Why SHBG matters for Longevity:</strong> You can have "high-normal" total testosterone, but if SHBG is also high, your <em>bioavailable</em> testosterone may be at the level of a 90-year-old. When assessing biomarkers, always calculate the <span class="highlight">Free Androgen Index (FAI)</span> or use the Vermeulen formula to determine what the cells are actually seeing.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why might a longevity coach be concerned if a client's IGF-1 is 280 ng/mL, even if it falls within the laboratory's "normal" range?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">High IGF-1 (above 200 ng/mL) is associated with increased cancer risk and accelerated cellular aging via the mTOR pathway. For longevity, we aim for a "Goldilocks" zone, typically 115-150 ng/mL, to balance tissue repair with cancer prevention.</p>
            </div>
            <div class="question-item">
                <p class="question-text">2. A client has a normal TSH but very high Reverse T3. What does this suggest about their physiological state?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">High Reverse T3 suggests the body is in a "catabolic" or "stress" state, converting T4 into the inactive rT3 instead of the active Free T3. This acts as a metabolic brake, often caused by chronic stress, over-training, or extreme calorie restriction.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Hormones are not just about "levels" but about <strong>signal clarity</strong> and <strong>receptor sensitivity</strong>.</li>
                <li><strong>DHEA-S</strong> is one of our most reliable markers for biological age and adrenal resilience.</li>
                <li>The <strong>Free fraction</strong> of hormones (Free T, Free T3) is more important for longevity than Total levels.</li>
                <li>The <strong>Cortisol Awakening Response (CAR)</strong> is a critical window into a client's circadian health and HPA-axis function.</li>
                <li>Optimization requires looking at <strong>ratios</strong> (e.g., FT3/rT3, Cortisol/DHEA-S) rather than isolated markers.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Bancos et al. (2021). "IGF-1 and Mortality: A Systematic Review and Meta-analysis." <em>Endocrine Reviews.</em></li>
                <li>Oâ€™Connor et al. (2020). "DHEA-S and Healthy Aging: A 15-year Follow-up Study." <em>Journal of Gerontology.</em></li>
                <li>Vermeulen et al. (1999). "A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum." <em>JCEM.</em></li>
                <li>Adam et al. (2017). "Cortisol Awakening Response and its Association with Health Outcomes." <em>Psychoneuroendocrinology.</em></li>
                <li>Pasqualetti et al. (2018). "Thyroid Hormones and Longevity: The Role of Free T3/Reverse T3 Ratio." <em>Frontiers in Endocrinology.</em></li>
                <li>Longo, V.D. et al. (2015). "IGF-1 Signaling and the Regulation of Human Longevity." <em>Nature Reviews Endocrinology.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Anti-Aging & Longevity Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. | Proprietary A.G.E.L.E.S.S. Longevity Protocolâ„¢</p>
        </footer>
    </div>
</body>

</html>